On February 27th, 2015, the national newspaper Corriere della Sera has published on its section “Corriere Sociale,” dedicated to volunteering and Third Sector, an article on CVBF and its activities in the field of rare diseases and paediatrics. The page describes the four main focus areas of the Consortium: Clinical Trials (promotion of an ethical use of medication, ethics and regulatory counselling, organisation and conduction of clinical trials, pharmacovigilance services, CRO and CME providers activities and drug management), Regulatory Consultancy (whose value lies in the set of competencies guaranteed by the consortium members), Scientific Research (in particular paediatric clinical research, conducted in the context of European projects), Training (with particular regard to the DEEP project and its significant contribution in the field of paediatric research, with the aim of making the iron chelating agent deferiprone- DFP, available in a new formulation specifically tested for children with β-thalassaemia and other transfusion dependent haemoglobinopathies). Here you can download the complete article.
CVBF, partner of the Gianni Benzi Pharmacological Research Foundation and the paediatric clinical research activities carried out through its DEEP project have been the object of an article published on “Il sole 24 ore – Eventi Sud” on 20th October with the title “CVBF – Innovazione nella ricerca clinica pediatrica” (CVBF – Innovation in paediatric clinical research). Donato Bonifazi, CEO of CVBF and Project Manager of one of CVBF main paediatric projects, DEEP (DEferiprone Evaluation in Paediatrics) has highlighted its value: “The DEEP project will also lead to the collection of information intended for regulatory purposes and may thus provide an important contribution to paediatric research in giving the opportunity to many children in the world to have a new syrup specifically tested for them “. […]
Pavia, November 25th, 2013. The first European project on paediatric chronic pain and the expression of a collaborative effort involving pharmacologists, clinical neurologists and paediatricians from 9 different European and extra-European countries, GAPP – GAbapentin in Paediatric Pain was officially kicked-off at the premises of Cascina Scova in Pavia, Italy, on November 18-20th 2013. […]